Skip to main content

#160404

Anti-50k glycoprotein [IVD3]

Cat. #160404

Anti-50k glycoprotein [IVD3]

Cat. #: 160404

Unit size: 100 ug

Availability: 10-12 weeks

Target: sarcolemma

Class: Monoclonal

Application: IP ; WB ; IHC

Reactivity: Rabbit

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: The University of Iowa

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-50k glycoprotein [IVD3]
  • Alternate name: 5-DAG, SL5
  • Research fields: Tissue-specific biology
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 50
  • Reactivity: Rabbit
  • Host: Mouse
  • Application: IP ; WB ; IHC
  • Description: Recognized only the non-reduced form of the 50K glycoprotein, part of the dystropoin-glycoprotein complex of skeletal muscle.

Target Details

  • Target: sarcolemma
  • Molecular weight: 50
  • Target background: Recognized only the non-reduced form of the 50K glycoprotein, part of the dystropoin-glycoprotein complex of skeletal muscle.

Applications

  • Application: IP ; WB ; IHC

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Klietsch et al. 1993. Circ Res. 72(2):349-60. PMID: 8418988.
  • Ervasti et al. 1990. Nature. 345(6273):315-9. PMID: 2188135.
  • Jorgensen et al. 1990. J Cell Biol. 110(4):1173-85. PMID: 2157716.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.